dpp-4 inhibitors vs. glp-1 agonist The effect of inhibitors, receptor agonists and SGLT-2 on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology GLP‑1 and GIP are incretin

dpp-4 inhibitors vs. glp-1 agonist

dpp-4 inhibitors vs. glp-1 agonist The effect of inhibitors, receptor agonists and SGLT-2 on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology GLP‑1 and GIP are incretin

Name: dpp-4 inhibitors vs. glp-1 agonist The effect of inhibitors, receptor agonists and SGLT-2 on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology GLP‑1 and GIP are incretin
Brand: themeproject.nl
SKU: 7050212795
Price: 27.90 USD
Availability: InStock
Rating: 4.844200000000001 (20 reviews)

SKU: 7050212795

4.8

EUR27.90 EUR76.90

Pay in 4 interest-free payments of $6.97 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 15 - Aug 20

Description

Product ID:13184485

doi: Mielgo-Ayuso, J., Pietrantonio, L., Viribay, A., Calleja-Gonzlez, J., Gonzlez-Bernal, J

It has been reported that GLP-1RAs can enhance bone mineral density (BMD), improve bone quality and prevent fractures in diabetic patients and cell and animal experiments further found that GLP-1RAs have excellent potential anti-osteoporosis benefits for postmenopausal osteoporosis, GIOP and senile osteoporosis (Zhang et al., 2018